Lu Kang Pharmaceutical (600789.SH): Obtained the registration certificate for Arirpitan Capsules.

Finance and Economics APP News, Shandong Kangyao Medicine (600789.SH) announced that recently, the company received the "Drug Registration Certificate" for Aripiprazole Capsules issued by the National Medical Products Administration, and the drug was approved for registration. Aripiprazole is a highly selective antagonist with high affinity for human substance P neurokinin 1 (NK1) receptors. When used in combination with other antiemetic drugs, it is suitable for preventing acute and delayed nausea and vomiting during the first and repeat treatments of highly emetogenic anti-tumor chemotherapy.